UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019426
Receipt number R000022467
Scientific Title A study of dermatological efficacy after continuous application of topical product (BSL02-1509AYM) in human skin
Date of disclosure of the study information 2015/10/30
Last modified on 2016/10/20 19:16:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of dermatological efficacy after continuous application of topical product (BSL02-1509AYM) in human skin

Acronym

A study of dermatological efficacy after continuous application of topical product (BSL02-1509AYM) in human skin

Scientific Title

A study of dermatological efficacy after continuous application of topical product (BSL02-1509AYM) in human skin

Scientific Title:Acronym

A study of dermatological efficacy after continuous application of topical product (BSL02-1509AYM) in human skin

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Dermatology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of skin condition by stratum corneum water content, transepidermal water loss, skin pH, photo image in skin surface, skin color, analysis of lipidome and metaborome in horny cell layer, evaluation of vascular function after repeated application of topical product for 4 and 8 weeks

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluation of skin condition by stratum corneum water content, transepidermal water loss, skin pH, photo image in skin surface, skin color, analysis of lipidome and metaborome in horny cell layer, evaluation of vascular function after repeated application of topical product for 4 and 8 weeks

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Topical application of both test product and control product for 4weeks and 8weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Male

Key inclusion criteria

1)Healthy males
2)Individuals who drink only a few cup of coffee per day

Key exclusion criteria

1)Individuals who have some skin diseases (atopic dermatitis and so on)
2)Individuals who have some skin troubles in applied positions
3)Individuals who already got dark skin with excessive sunburn
4)Individuals who play outdoor actions with excessive sunburn routinely
5)Individuals who apply cosmetics or drugs for beauty to target skins, and take drugs for improvement of fleck, age spot and suntan
6)Individuals who have some diseases (endocrine, liver, kidney, heart and blood pressure and so on), or have had some diseases until a month
7)Individuals who have some diseases (hypertension, cardiac disease, diabetes, Raynaud disease, rosacea, telangiectasia) or feel excessive sensitivity to cold
8)Individuals who have an abnormal cardiac rhythm
9)Individuals who usually take some medications
10)Individuals who got some cosmetic surgery/implant
11)Individuals who have or might have same dermatological diseases (pollen, rhinitis, and allergic dermatitis)
12)Individuals who have or might have same allergy of medicine
13)Smoker
14)Individuals who drink much coffee per day
15)Individuals who are judged inappropriate for the study by study director and/or study doctor

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takatoshi Murase

Organization

Kao Corporation

Division name

R&D -Core Technology- Biological Science Research

Zip code


Address

2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, JAPAN

TEL

0285-68-7871

Email

murase.takatoshi@kao.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Katsuyuki Yuki

Organization

Kao Corporation

Division name

R&D -Core Technology- Biological Science Research

Zip code


Address

2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, JAPAN

TEL

0285-68-7460

Homepage URL


Email

yuki.katsuyuki@kao.co.jp


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

花王株式会社(栃木県)


Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 10 Month 20 Day

Date of IRB


Anticipated trial start date

2015 Year 11 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 10 Month 20 Day

Last modified on

2016 Year 10 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022467


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name